Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M875Revenue $M276Net Margin (%)-9.6Altman Z-Score11.9
Enterprise Value $M747EPS $-0.8Operating Margin %-11.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.2Pre-tax Margin (%)-11.5Higher ROA y-yN
Price/Book5.610-y EBITDA Growth Rate %--Quick Ratio4.1Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %--Current Ratio4.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-14.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-18.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M32.3ROIC % (ttm)-69.9Gross Margin Increase y-yN

Gurus Latest Trades with GHDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GHDXDavid Swensen 2013-03-31 Sold Out -2.8%$26.72 - $29.65
($28.5)
$ 27.12-5%Sold Out0
GHDXDavid Swensen 2012-12-31 Buy 2.8%$26.42 - $36.8
($30.13)
$ 27.12-10%New holding37,861
GHDXDavid Swensen 2011-03-31 Sold Out -0.93%$21.08 - $26.18
($23.29)
$ 27.1216%Sold Out0
GHDXDavid Swensen 2010-12-31 Buy 0.93%$13.18 - $23.52
($17.74)
$ 27.1253%New holding38,243
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GHDX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GHDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cole G BradleyCOO 2015-05-12Sell4,000$27.54-0.87 view
Popovits Kimberly JPresident and CEO 2015-04-13Sell3,000$31.28-12.72 view
Cole G BradleyCOO 2015-04-07Sell4,000$30.44-10.32 view
Popovits Kimberly JPresident and CEO 2015-03-12Sell3,000$31.91-14.45 view
Cole G BradleyCOO 2015-03-10Sell4,000$31.84-14.26 view
Popovits Kimberly JPresident and CEO 2015-02-12Sell3,000$29.86-8.57 view
Cole G BradleyCOO 2015-02-10Sell4,000$31.37-12.97 view
LIVINGSTON RANDALL SDirector 2015-02-02Sell1,000$31.93-14.5 view
Popovits Kimberly JPresident and CEO 2015-01-12Sell3,000$33.46-18.41 view
Popovits Kimberly JPresident and CEO 2014-12-11Sell3,000$32.99-17.25 view

Press Releases about GHDX :

    Quarterly/Annual Reports about GHDX:

    News about GHDX:

    Articles On GuruFocus.com
    CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares Jul 13 2012 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Mar 16 2011 
    Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Mar 16 2011 
    Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Mar 14 2011 
    Genomic Health Inc. (GHDX) COO G Bradley Cole sells 2,500 Shares Mar 10 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Feb 14 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Jan 19 2011 

    More From Other Websites
    Two Picks in Small-Cap Pharma With Catalysts May 28 2015
    Genomic's Prostate Cancer Test Recommended by Palmetto - Analyst Blog May 27 2015
    Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference May 27 2015
    Multiple Oncotype DX® Presentations at the American Society of Clinical Oncology Annual Meeting... May 27 2015
    Multiple Oncotype DX® Presentations at the American Society of Clinical Oncology Annual Meeting... May 27 2015
    Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference May 27 2015
    Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto GBA® on... May 21 2015
    Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto GBA® on... May 21 2015
    UCSF-led Study Shows Oncotype DX® and MRI May Provide Independent Information in Favorable Risk... May 20 2015
    UCSF-led Study Shows Oncotype DX® and MRI May Provide Independent Information in Favorable Risk... May 20 2015
    Genomic Health's Loss Lingers, Profits Expected in 4Q15 - Analyst Blog May 19 2015
    Genomic Health Advances Liquid Biopsy Pipeline, Shows Ability to Accurately Monitor Urine for... May 18 2015
    Genomic Health Advances Liquid Biopsy Pipeline, Shows Ability to Accurately Monitor Urine for... May 18 2015
    GENOMIC HEALTH INC Financials May 15 2015
    Oncotype DX® Prostate Cancer Test Improves Risk Assessment for One in Four Men and Reduces Overall... May 15 2015
    Oncotype DX® Prostate Cancer Test Improves Risk Assessment for One in Four Men and Reduces Overall... May 15 2015
    St. Gallen International Breast Cancer Guidelines for the Third Time Distinguish Oncotype DX® as... May 11 2015
    10-Q for Genomic Health, Inc. May 09 2015
    GENOMIC HEALTH INC Files SEC form 10-Q, Quarterly Report May 07 2015
    Genomic Health to Present Multiple Oncotype DX® Studies and Positive Liquid Biopsy Results at... May 07 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK